Co-Authors
This is a "connection" page, showing publications co-authored by Christl Donnelly and Azra Ghani.
Connection Strength
1.408
-
The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science. 2020 07 24; 369(6502):413-422.
Score: 0.222
-
COVID-19 and the difficulty of inferring epidemiological parameters from clinical data - Authors' reply. Lancet Infect Dis. 2021 01; 21(1):28.
Score: 0.221
-
Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis. 2004 Nov; 4(11):672-83.
Score: 0.075
-
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003 May 24; 361(9371):1761-6.
Score: 0.068
-
Viral replication under combination antiretroviral therapy: a comparison of four different regimens. J Acquir Immune Defic Syndr. 2002 Jun 01; 30(2):167-76.
Score: 0.064
-
Modelling intensive care unit capacity under different epidemiological scenarios of the COVID-19 pandemic in three Western European countries. Int J Epidemiol. 2021 07 09; 50(3):753-767.
Score: 0.060
-
Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England. Sci Transl Med. 2021 07 14; 13(602).
Score: 0.060
-
The J-IDEA Pandemic Planner: A Framework for Implementing Hospital Provision Interventions During the COVID-19 Pandemic. Med Care. 2021 05 01; 59(5):371-378.
Score: 0.059
-
State-level tracking of COVID-19 in the United States. Nat Commun. 2020 12 03; 11(1):6189.
Score: 0.057
-
Host or pathogen-related factors in COVID-19 severity? - Authors' reply. Lancet. 2020 10 31; 396(10260):1397.
Score: 0.057
-
Database of epidemic trends and control measures during the first wave of COVID-19 in mainland China. Int J Infect Dis. 2021 Jan; 102:463-471.
Score: 0.057
-
Response to COVID-19 in South Korea and implications for lifting stringent interventions. BMC Med. 2020 10 09; 18(1):321.
Score: 0.057
-
Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment. Wellcome Open Res. 2020; 5:81.
Score: 0.057
-
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020 09; 8(9):e1132-e1141.
Score: 0.056
-
Have deaths from COVID-19 in Europe plateaued due to herd immunity? Lancet. 2020 06 20; 395(10241):e110-e111.
Score: 0.055
-
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 08; 584(7820):257-261.
Score: 0.055
-
Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 06; 20(6):669-677.
Score: 0.055
-
Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. Epidemiol Infect. 2006 Apr; 134(2):211-21.
Score: 0.021
-
SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004 Sep; 10(9):1653-6.
Score: 0.019
-
Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29; 359(1447):1091-105.
Score: 0.018
-
Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003 Jun 20; 300(5627):1961-6.
Score: 0.017